Failing to withdraw a required minimum distribution (RMD) from your own or an inherited IRA by the deadline results in a big tax code penalty: 50%. That's right. If you were supposed to take out a minimum of $4,000 and (oops!) did not do so, you have the privilege of writing the
If you do not make a required minimum distribution (RMD) from your own or an inherited IRA by the specified deadline, the IRS could hit you with a big penalty - 50%! For example, if you were required to withdraw a minimum of $4,000 and you did not, you would be obliged to pay $2
On the lookout for a Non US - Equity fund? Starting with Fidelity International Capital Appreciation (FIVFX) is one possibility. FIVFX holds a Zacks Mutual Fund Rank of 2 (Buy), which is based on nine forecasting factors like size, cost, and past performance.
Having trouble finding a Sector - Real Estate fund? Fidelity Real Estate Investment (FRESX) is a potential starting point. FRESX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on nine forecasting factors like size, cost, and past performance.
If you have been looking for Global - Equity funds, a place to start could be Fidelity Trend Fund (FTRNX). FTRNX carries a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on nine forecasting factors like size, cost, and past performance.
If you've been stuck searching for Mid Cap Growth funds, consider MSIFT Mid Cap Growth Portfolio I (MPEGX) as a possibility. MPEGX holds a Zacks Mutual Fund Rank of 2 (Buy), which is based on nine forecasting factors like size, cost, and past performance.
Having trouble finding a Large Cap Growth fund? Fidelity Growth Discovery (FDSVX) is a potential starting point. FDSVX holds a Zacks Mutual Fund Rank of 2 (Buy), which is based on nine forecasting factors like size, cost, and past performance.
Maybe you're a seasoned investor and have a good track record with stock-picking. And you may have a robust retirement portfolio - perhaps including some Zacks Top Retirement stock selections such as:
Shares of Amedisys (AMED) have been strong performers lately, with the stock up 30.3% over the past month. The stock hit a new 52-week high of $206.1 in the previous session. Amedisys has gained 19.2% since the start of the year compared to the -7% move for the Zacks Medical sec
The beginning of this tough earnings season didn’t scare the market on Tuesday, as the major indices got back to rallying on cautious optimism that the coronavirus is finally running out of steam.
The NASDAQ now has a FOUR-DAY winning streak as tech is getting a lot of l